WHO ICTRP trial
Long-term consequences of COVID-19 for pulmonary and neurocognitive disorders
DRKS00023806 · German Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | DRKS00023806 |
|---|---|
| Public title | Long-term consequences of COVID-19 for pulmonary and neurocognitive disorders |
| Scientific title | Long-term consequences of COVID-19 for pulmonary and neurocognitive disorders - COVIMMUNE-Clin |
| Primary sponsor | Klinik für Neurodegenerative Erkrankungen und GerontopsychiatrieUniversitätsklinikum Bonn |
| Registry | German Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | observational |
| Countries | Germany |
| Conditions | SARS-CoV-2 U07.1;COVID-19, virus identified;U07.1 |
| Interventions | Group 1: Recovered patients after asymptomatic course of SARS-CoV-2 infection. Patients undergo cognitive, neurological (including MRI) and pneumonological examinations. Group 2: Recovered patients after severe SARS-CoV-2 positive. Subjects… |
| Registration date | Mar 16, 2021 |
| Target size | 150 |
| Registry page | drks.de |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: